Most Recent
The High Court has dismissed the ACCC's bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
PriceWaterHouse Coopers has received the green light to launch court action to pursue its cross claims against failed educational training company Vocation.
Japanese car parts manufacturer Yazaki will have to pay a $46 million penalty for price-fixing, now that the High Court has refused to hear its appeal of the record competition fine.
The ACCC secured $120.1 million in competition penalties in the 2017-18 financial year, including a record $46 million fine, and with a strong influx of immunity applications throughout the year, the cartel cop shows no signs of slowing down.
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Medical device maker American Medical Systems, which is facing a class action over allegedly faulty pelvic mesh implants, has taken a page from the Ethicon pelvic mesh defence playbook, calling on the court to restrict the dates for group membership.
Former ABC boss Michelle Guthrie has launched legal proceedings over her firing last month from the ABC, making an adverse action claim against the broadcaster.
Senator Sarah Hanson-Young has accused Senator David Leyonhjelm of using parliamentary privilege and fabricated remarks to shut down a defamation case she lodged in August.
Liquidators for Dick Smith don't want potential group members in two class actions against the failed retailer to learn about a new registration deadline by email, saying it would amount to spam and harassment.